Coeptis Therapeutics Holdings

COEP41

Penny Stock

$0.19arrow_drop_down3.89%-$0.00

Penny Stock

COEP41

$0.19

arrow_drop_down3.89%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.20
Prev. Close	$0.20
EPS	-0.47
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$7.90M
PE Ratio	-

	LOW	HIGH
Day Range	0.19	0.21
52 Week Range	0.15	1.38

Ratios

Revenue	-


Earnings Growth %	-
EBITDA Margin %	-

EPS	-0.47

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Coeptis Therapeutics Holdings (COEP)

Coeptis Therapeutics Holdings, Inc. (COEP) is a biotechnology company focused on the development of innovative therapeutics for various diseases. With a strong emphasis on research and development, COEP is dedicated to bringing novel treatments to patients in need. The company's stock price history has shown steady growth over the years, reflecting investor confidence in its potential. COEP's quote indicates that it is a publicly traded company, allowing investors to buy and sell its shares on the stock market. This provides an opportunity for individuals to participate in the company's growth and potentially profit from its success.

News surrounding Coeptis Therapeutics Holdings, Inc. (COEP) is of great interest to investors and stakeholders. Staying informed about the latest developments can help investors make informed decisions about their investments. COEP's stock analysis provides valuable insights into the company's financial performance, growth prospects, and market trends. It enables investors to assess the company's strengths and weaknesses, identify potential risks, and make smart investment decisions. Additionally, COEP's smart analysis offers a comprehensive evaluation of the company's overall performance, helping investors gain a deeper understanding of its market position and potential future growth.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. David Mehalick
Headquarters: Wexford
Employees: 4
Exchange: NASDAQ

add Coeptis Therapeutics Holdings to watchlist

Keep an eye on Coeptis Therapeutics Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Coeptis Therapeutics Holdings's (COEP) price per share?

The current price per share for Coeptis Therapeutics Holdings (COEP) is $0.2. The stock has seen a price change of -$0.01 recently, indicating a -3.89% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Coeptis Therapeutics Holdings (COEP)?

For Coeptis Therapeutics Holdings (COEP), the 52-week high is $1.38, which is 593.47% from the current price. The 52-week low is $0.15, the current price is 31.79% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Coeptis Therapeutics Holdings (COEP) a growth stock?

Coeptis Therapeutics Holdings (COEP) has shown an average price growth of -6.65% over the past three years. It has received a score of -2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Coeptis Therapeutics Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Coeptis Therapeutics Holdings (COEP) stock price performance year to date (YTD)?

As of the latest data, Coeptis Therapeutics Holdings (COEP) has a year-to-date price change of -74.1%. Over the past month, the stock has experienced a price change of 0.2%. Over the last three months, the change has been -1.44%. Over the past six months, the figure is -43.99%.

help

Is Coeptis Therapeutics Holdings (COEP) a profitable company?

Coeptis Therapeutics Holdings (COEP) has a net income of -$37.57M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$34.2M. Furthermore, the EBITDA is -$16.02M.

help

What is the market capitalization of Coeptis Therapeutics Holdings (COEP)?

Coeptis Therapeutics Holdings (COEP) has a market capitalization of $7.9M. The average daily trading volume is 0.2, indicating the stock's liquidity and investor engagement.

News

Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying

UPGRADES

DOWNGRADES